VMC
69
9
ACN
18
7
XRX
32
8
ADSK
49
4
JPM
66
6
ORCL
26
3
NOV
70
6
PCG
81
15
ROK
62
2
EXC
58
5
HON
52
2
MCHP
60
-2
PSA
53
16
FITB
82
3
CFG
77
2
APA
52
6
FCX
72
-2
SYK
33
-4
EMR
76
6
WEC
45
2
VMC
69
9
ACN
18
7
XRX
32
8
ADSK
49
4
JPM
66
6
ORCL
26
3
NOV
70
6
PCG
81
15
ROK
62
2
EXC
58
5
HON
52
2
MCHP
60
-2
PSA
53
16
FITB
82
3
CFG
77
2
APA
52
6
FCX
72
-2
SYK
33
-4
EMR
76
6
WEC
45
2
Financhill
Back

Rigel Pharmaceuticals, Inc. Stock Predictions

The Next AI Breakouts Won't Talk Like ChatGPT

*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com
Sell
50

RIGL
Rigel Pharmaceuticals, Inc.

Last Price:
$34.16
Seasonality Move:
-1.1%

7 Day Trial

ALL ACCESS PASS

$ 7

$10K Investment in Nvidia Could've Made $2.5M

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Rigel Pharmaceuticals, Inc. Stock Forecast

  • Over the next 52 weeks, Rigel Pharmaceuticals, Inc. has on average historically risen by 7.2% based on the past 25 years of stock performance.
  • Rigel Pharmaceuticals, Inc. has risen higher in 11 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 44%
  • Is Rigel Pharmaceuticals, Inc. Stock Undervalued?
    The current Rigel Pharmaceuticals, Inc. [RIGL] share price is $34.15. The Score for RIGL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • RIGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Rigel Pharmaceuticals, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Rigel Pharmaceuticals, Inc. has on average historically risen by 7.2% based on the past 25 years of stock performance.

Rigel Pharmaceuticals, Inc. Stock Rating

Sell
50
Rigel Pharmaceuticals, Inc. (RIGL) is a Sell

Is Rigel Pharmaceuticals, Inc. overpriced?

  • Rigel Pharmaceuticals, Inc. has risen higher in 11 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 44%

Rigel Pharmaceuticals, Inc. Stock Price History

Is RIGL stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RIGL is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
rigel.com

52-Week Data

52-Week High:
52.24
52-Week Low:
15.50

Prediction Charts

Market Cap:
619.9M
Price in USD:
34.15
Volume:
353.9K
Beta:
1.47

Technical Analysis

SMA50:
41.46
SMA100:
37.14
SMA200:
30.88
52-Wk Change:
40.02%

Stock Predictions

  • Is Rigel Pharmaceuticals, Inc. stock public?
    Yes, Rigel Pharmaceuticals, Inc. is a publicly traded company.
  • What is the Rigel Pharmaceuticals, Inc. stock quote today?
    The Rigel Pharmaceuticals, Inc. stock price is 34.15 USD today.
  • How to buy Rigel Pharmaceuticals, Inc. stock online?
    You can buy Rigel Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-20 36.94 36.34 37.20 36.02
Jan-21 36.61 37.64 37.79 35.79
Jan-22 37.35 37.93 38.69 37.02
Jan-23 37.16 36.96 37.81 36.60
Jan-26 36.76 37.00 37.55 36.38
Jan-27 37.24 37.25 37.83 36.96
Jan-28 37.20 35.25 37.40 35.13
Jan-29 35.21 35.16 35.94 34.72
Jan-30 34.87 34.86 35.43 33.94
Feb-2 34.86 36.01 36.43 34.59
Feb-3 35.72 36.20 36.65 35.46
Feb-4 35.87 34.95 36.34 34.61
Feb-5 34.35 33.22 35.68 33.05
Feb-6 33.46 34.15 35.00 33.46

Rigel Pharmaceuticals, Inc. Earnings

Rigel Pharmaceuticals, Inc. Earnings Report: Per Share Rigel Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Rigel Pharmaceuticals, Inc. Forecast Revenue Growth

Rigel Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Rigel Pharmaceuticals, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.97 per share, and an increase next year of $0.98 per share.

* Rigel Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.